Lack of innovation fuelling AMR
Lack of innovation set to undermine antibiotic performance and health gains: Development of new antibacterial treatments is inadequate to address…
Lack of innovation set to undermine antibiotic performance and health gains: Development of new antibacterial treatments is inadequate to address…
A new study will look at how patients, who receive stem cell transplants for blood cancers and blood disorders, react…
Tissue Access for Patient Benefit (TAPb) is a UCL and Royal Free NHS Foundation Trust initiative, based in the UCL…
This website uses cookies.